Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 30 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
291 22.0 months Metastatic colorectal cancer 5 Chemotherapy
Klinikum Sankt Marien Germany 1/2011
Treatment Details: Patients: This phase III study involved metastatic colorectal cancer patients who were divided into two separate treatment groups. Group A consisted of 238 patients with a median age of 63
 
292 22.0 months Metastatic breast cancer 4 Biologic therapy
Chemotherapy
Croissance et Cancer France 12/2009
Treatment Details: Patients: This phase 2 study involved 25 women with metastatic breast cancer. Their median age was 58, ranging from 32 to 71 years. The majority (84%) were post-menopausal. Treatment: T
 
293 22.0 months Locally advanced NSCLC 3 Chemotherapy
Radiation
Surgery
Gazi University Faculty of Medicine Turkey 2/2009
Treatment Details: Patients: This study involved 54 patients with unresectable locally advanced non-small cell lung cancer. Their median age was 58, ranging from 38 to 76 years. Treatment: Patients were
 
294 22.0 months Metastatic breast cancer 4 Chemotherapy
Institut Claudius Regaud France 8/2007
Treatment Details: Patients: This phase II study involved 65 patients with metastatic breast cancer. The median age was 52, ranging from 33 to 80 years old. The majority of women were premenopausal (65%).
 
295 22.0 months Hormone-refractory prostate cancer 2 Immunotherapy
Kurume University School of Medicine Japan 1/2004
Treatment Details: Patients: This Phase I trial involved 10 patients with metastatic hormone refractory prostate cancer. All patients were also positive for human leukocyte antigen (HLA)-A2. Treatment: Th
 
296 21.8 months Metastatic, Castration-Resistant Prostate Cancer 5 Chemotherapy
Hormone
Changhai Hospital China 1/2015
Treatment Details: Patients: This study involved metastatic castration-resistant patients who were divided into two separate treatment groups. Group A consisted of 113 patients with a median age of 70.7 year
 
297 21.7 months GBM Chemotherapy
Radiation
University Hospital Lausanne Switzerland 3/2005
Treatment Details: Patients: This trial involved 206 patients with glioblastoma. Demographic information on the patients was not reported. The patients were randomly divided into two groups. In addition, al
 
298 21.7 months Metastatic breast cancer 5 Chemotherapy
UCLA Medical Center United States 3/2003
Treatment Details: Patients: This Phase III study involved a total of 429 patients with metastatic breast cancer. Patients were divided into two groups group 1 comprised 214 patients (213 received treatment
 
299 21.7 months metastatic breast cancer 5 Chemotherapy
Radiation
Duke University Medical Center United States 6/2006
Treatment Details: Patients: This Phase III trial involved a total 85 patients of which 69 were randomized to one of two groups. Group A had 35 women and Group B had 34 women. In both groups the average age
 
300 21.7 months Stage III NSCLC 5 Chemotherapy
Radiation
Indiana University Melvin and Bren Simon Cancer Center United States 12/2008
Treatment Details: Patients: This phase 3 study involved 203 patients with inoperable stage III non-small cell lung cancer. Women made up 34% of the patients. The median age was 63 years. Treatment: Pati
 
Page 30 of 187  | Previous Page  | Next Page